Interim Results
Summary by AI BETAClose X
1 December 2025
Peel Hunt Limited
Interim Results for the six months ended 30 September 2025
Strong performance and strategic progress
Peel Hunt Limited ('Peel Hunt', the 'Company') together with its subsidiaries (the 'Group') today announces unaudited interim results for the period ended 30 September 2025 ('H1 FY26'). FY26 refers to the financial year ending on 31 March 2026.
Strategic Progress & Group Profitability
· During the challenging market conditions of the past three years, we have remained focused on executing our strategy: evolving our corporate client base towards ambitious mid-cap and growth companies, building a high-quality M&A franchise, pursuing our ambition to be the leading UK equities platform, adding incremental liquidity to our Execution Services platform, and deploying proprietary technology to maintain our competitive edge. This strategic progress is reflected in our financial performance for H1 FY26.
· We continue to focus on delivering sustainable profitability through the economic cycle and have reduced fixed costs while maintaining investment in our client service capabilities. As a result, our strong revenue performance is now supported by a leaner and better-aligned cost base, which is evident in the Group's underlying profitability for H1 FY26.
Financial & Operating Highlights
· Group revenue of £74.4m (H1 FY25: £53.8m), representing a 38.3% year-on-year increase
· Profit before tax of £11.5m (H1 FY25: £1.2m), representing a 858.3% year-on-year increase
· Adjusted profit before tax(1) of £18.7m (H1 FY25: £4.6m), representing a 306.5% year-on-year increase
· Net assets of £100.7m (FY25: £88.7m) and cash balances of £13.6m (FY25: £20.4m), with the reduction in cash largely due to debt repayment and increased investment into our trading book
· Capital and liquidity remain comfortably in excess of regulatory requirements
· Headcount reduced by over 15% from its peak in FY23 and underlying fixed costs are down by approximately £5.0m for FY26
Divisional Performance
Investment Banking
· Revenue of £32.9m (H1 FY25: £22.6m), an increase of 45.6% year-on-year
· Strong performance in our core equity capital markets business, executing multiple equity fundraises and block trades, and being the most active investment bank for all UK ECM transactions in H1 with a market share of approximately 17% for the period
· Our M&A advisory business delivered an exceptional performance - we acted as financial adviser on 10 M&A transactions with a total deal value of £8.1bn, ranking third in the UK public M&A league tables behind only global investment banks
· Demonstrating the success of our diversification strategy, M&A fees have significantly contributed to Investment Banking revenue over the past three years, accounting for approximately 70% of overall Investment Banking deal fees in H1 FY26
· The average market capitalisation of our corporate clients has nearly doubled over the last three years to over £1bn, with the median market cap rising to £457m
· We now act for 57 FTSE 350 clients, including five FTSE 100 companies and 52 FTSE 250 companies, as well as a strong portfolio of exciting growth companies
Research & Distribution
· Revenue of £13.9m (H1 FY25: £13.6m), an increase of 2.2% year-on-year
· Continued investment in our distribution capabilities, particularly internationally. We have now opened Peel Hunt Middle East in Abu Dhabi, complementing our existing office network in London, New York and Copenhagen
· With one of the largest global sales teams focused on UK equities, targeting international and domestic funds, we believe we offer the leading platform for UK mid-cap and growth companies
Execution Services
· Delivered its best half-year performance since the Covid lockdown period, despite increased market competition
· Revenue of £27.6m (H1 FY25: £17.6m), an increase of 56.8% year-on-year
Financial and operating highlights
|
Financial highlights |
H1 FY26 |
H1 FY25 |
Change |
|
Revenue |
£74.4m |
£53.8m |
38.3% |
|
Profit before tax |
£11.5m |
£1.2m |
858.3% |
|
Adjusted profit before tax(1) |
£18.7m |
£4.6m |
306.5% |
|
Profit after tax |
£8.3m |
£0.7m |
1,085.7% |
|
Compensation ratio |
57.9% |
61.2% |
(3.3)ppts |
|
Operating highlights |
H1 FY26 |
FY25 |
Change |
|
Cash |
£13.6m |
£20.4m |
(33.3)% |
|
Net assets |
£100.7m |
£88.7m |
13.5% |
|
Investment Banking clients |
143 |
147 |
(2.7)% |
|
Average market cap of clients |
£1,096.0m |
£869.3m |
26.1% |
Note:
(1) Adjusted profit before tax is a non-statutory measure, which shows the underlying performance of the Group excluding share-based payment charges and exceptional items. This is calculated as the Group's profit before tax less share-based payment charges of £5.0m (H1 FY25: £3.4m) and exceptional items amounting to £2.2m (H1 FY25: £nil). Exceptional items relate to staff restructuring costs.
Steven Fine, Chief Executive Officer, commented:
"I am delighted with the Group's strong financial performance in the first half, which reflects the significant strategic progress we have made in recent years.
Each part of our business delivered year-on-year growth. Our core ECM franchise continues to strengthen, as demonstrated by our being the most active investment bank in UK ECM in H1 FY26, while our M&A advisory business ranked third in the UK league tables. Execution Services also delivered its best half-year performance since the Covid lockdown period.
We are fortunate to work with outstanding colleagues and an exceptional client base, whom we were proud to support across a broad range of value-creating transactions.
The second half has started strongly, with the Group continuing to play leading roles across both M&A and ECM mandates. Consequently, we are confident in meeting market expectations for the full financial year."
For further information, please contact:
Peel Hunt: via Sodali & Co
Steven Fine, CEO
Michael Lee, COO
Billy Neve, Group Finance Director
Sodali & Co (Financial PR): +44 (0)20 7100 6451
Justin Griffiths
Gilly Lock
Russ Lynch
peelhunt@sodali.com
Grant Thornton UK LLP (Nominated Adviser): +44 (0)20 7383 5100
Philip Secrett
Colin Aaronson
Elliot Peters
Keefe, Bruyette & Woods (Corporate Broker): +44 (0) 20 7710 7600
Alistair McKay
Alberto Moreno Blasco
Fred Walsh
Notes to editors
About Peel Hunt
Peel Hunt is a leading international investment bank specialising in supporting UK mid-cap and growth companies. It provides integrated investment banking advice and services to UK corporates, including equity capital markets, private capital markets, M&A, debt advisory, investor relations and corporate broking. The Company's joined up approach combines these services with expert research and distribution and an execution services hub that provides liquidity to the UK capital markets, delivering value to global institutions and trading counterparties alike. The Company is admitted to trading on AIM (LON: PEEL) and has offices in London, New York, Copenhagen and Abu Dhabi.
Market conditions
Although conditions improved following the initial impact of 'Liberation Day' in the US and we saw an increase in equity issuances during H1 FY26, overall activity continues to remain significantly below historical averages. The changes to the UK's regulatory regime, particularly with respect to secondary issuances by listed companies, appear to be having a positive impact, and we expect this to continue once the further changes to the UK's prospectus regime come into effect in January 2026. IPO activity remained low during H1 FY26, although we saw an initial re-opening of the IPO market in September and October 2025, with a number of companies coming to market in London. M&A bid activity continued at pace throughout H1 FY26, with 60 transactions announced across the market during the period and there were ten active bids for FTSE 350 companies as at 30 September 2025.
Global and domestic indices reached a number of highs during the period with both the FTSE 100 and FTSE 250 rising by 8.9% and 13% respectively as part of a global rally in equity markets. Outflows from UK equities persisted throughout the period, and we now await the impact of Budget changes on investor sentiment towards the UK. Following a prolonged period of pre-Budget speculation, businesses and investors now have greater clarity from which they can start to plan. The key measures were generally well received by markets, particularly the creation of additional headroom against the chancellor's fiscal rules. Initiatives such as a stamp duty holiday on IPOs and adjustments to the ISA framework are intended to support UK capital markets and encourage investment in British companies. These developments, alongside the 'Entrepreneurship in the UK' paper published simultaneously, represent positive steps toward enhancing the UK's attractiveness for growth businesses and long-term investors.
Overview of results
Group revenue for the period was £74.4m (H1 FY25: £53.8m) with a profit before tax of £11.5m (H1 FY25: £1.2m), reflecting strong performances in our Execution Services business and M&A advisory franchise, and resilient performances by our other business divisions. Our adjusted profit before tax, which shows the underlying performance of the Group excluding share-based payment charges and exceptional items, was £18.7m (H1 FY25: £4.6m). Our balance sheet remained strong, with net assets of £100.7m as at 30 September 2025 (FY25: £88.7m), and with liquidity and capital comfortably in excess of regulatory requirements. Cash balances of £13.6m (FY25: £20.4m) reduced largely due to debt repayment and increased investment into our trading book.
Divisional reviews
Investment Banking
|
|
H1 FY26 |
H1 FY25 |
Change |
|
Investment Banking fees |
£28.3m |
£18.4m |
53.8% |
|
Investment Banking retainers |
£4.6m |
£4.2m |
9.5% |
|
Investment Banking revenue |
£32.9m |
£22.6m |
45.6% |
In Investment Banking, revenue increased by 45.6% to £32.9m (H1 FY25: £22.6m). M&A advisory fees were the largest proportion of overall Investment Banking deal revenue in the period, reflecting our M&A franchise's exceptional performance where we acted as financial adviser on a number of sizeable public M&A transactions. This was coupled with a solid performance from our equity capital markets ('ECM') business particularly during July and August 2025, where we acted on a number of sizeable fundraisings and block trades. Whilst the absolute revenue generated from our ECM business was low relative to historic standards, Peel Hunt was the most active investment bank across all UK ECM transactions in H1 FY26, with a market share by value of approximately 17%.
The slight increase in revenue from retainers reflects an uptick in annual retainer fees and our successful efforts to actively evolve the quality of our corporate client base. During the period, we had a number of corporate client wins, as well as successful organic growth of our existing clients leading to several index promotions, combined with a number of move ups from AIM to the Main Market of the London Stock Exchange of our existing corporate clients. As a result, we now act for 57 FTSE 350 companies (five FTSE 100 companies and 52 FTSE 250 companies), as well as a strong portfolio of exciting growth companies on AIM and the Main Market. Consequently, the average market capitalisation of our retained corporate clients has risen by 22.9% since the end of FY25, from approximately £869.3m to approximately £1,096.0m, and the aggregate market capitalisation of our corporate client list has risen by 25% to approximately £156bn.
Our focus on distribution, advice, market share, influence and access has continued to extend our reach as a trusted, well connected and stable investment banking partner of choice to UK mid-cap and growth companies.
Research & Distribution
|
|
H1 FY26 |
H1 FY25 |
Change |
|
Research payments (including commission sharing arrangements) |
£2.5m |
£2.7m |
(7.4)% |
|
Execution commission (including core trading) |
£11.4m |
£10.9m |
4.6% |
|
Research payments and execution commission |
£13.9m |
£13.6m |
2.2% |
Revenues in our Research & Distribution business were up on the same period last year at £13.9m (H1 FY25: £13.6m), despite a small decrease in research payments. Outflows from UK equities persisted throughout the period, and we now await the impact of Budget changes on investor sentiment towards the UK. The increase in execution commission was due, in part, to our continued focus on building out our capabilities for our clients.
In Research, revenue from research payments remained consistent year on year. We continued to develop and deploy AI applications and to seek innovative ways to interact with our significant data base of proprietary research.
Execution Services
|
|
H1 FY26 |
H1 FY25 |
Change |
|
Execution Services revenue |
£27.6 |
£17.6m |
56.8% |
Execution Services revenue for H1 FY26 was £27.6m, an increase of 56.8% year on year (H1 FY25: £17.6m). The strong performance in the first six months of the year was driven primarily by the team's ability to capture market opportunities and maintain a leading position as a liquidity provider. Alongside this, continued investment in proprietary technology has ensured that our Execution Services platform remains highly competitive.
Capital and liquidity
Net assets remained strong at £100.7m as at 30 September 2025 (H1 FY25: £88.7m).
Our cash position decreased as we repaid £3.0m of the senior facility agreement and increased investment into our trading book. This strategic deployment of capital has delivered a higher rate of return, when compared to the prior year. This reinforces our commitment and ability to dynamically manage capital in changing market conditions in order to maximise shareholder value.
Long-term debt was £6.0m at 30 September 2025, and we have access to an additional £30.0m of funding facilities, comprising £20.0m under the Revolving Credit Facility and a £10.0m overdraft facility. Both were undrawn at the end of the period.
We continue to operate well in excess of our regulatory capital requirements with own funds requirements coverage over net assets of 442% at the end of H1 FY26 compared to 417% at the end of FY25. The increase in coverage from FY25 was due to an increase in Group net assets while maintaining risk exposures within agreed limits.
In Q1 FY26, Retail Book Holdings Limited (RBHL) successfully carried out an equity fundraise. Following completion, the Group's equity interest in RBHL has decreased to 40.95% meaning RBHL and Retail Book Limited (RBL) are no longer subsidiaries and are no longer consolidated in the financial statements of the Group. The assets and liabilities of RBHL and RBL were derecognised (including non-controlling interests) and an investment in associate has been recorded.
Costs and people
|
|
H1 FY26 |
H1 FY25 |
Change |
|
Staff costs |
£43.1m |
£32.9m |
31.0% |
|
Non-staff costs |
£19.1m |
£19.6m |
(2.6)% |
|
Total admin costs |
£62.2m |
£52.5m |
18.5% |
|
Compensation ratio |
57.9% |
61.2% |
(3.3)ppts |
|
Non-staff costs ratio |
25.7% |
36.4% |
(10.7)ppts |
|
Change in headcount(1) |
(9.7)% |
(3.9)% |
(5.8)ppts |
|
|
|
|
|
|
Adjusted staff costs(2) |
£35.9m |
£29.5m |
21.7% |
|
Non-staff costs |
£19.1m |
£19.6m |
(2.6)% |
|
Adjusted admin costs(2) |
£55.0m |
£49.1m |
12.0% |
|
Adjusted compensation ratio |
48.3% |
54.8% |
(6.5)ppts |
|
Non-staff costs ratio |
25.7% |
36.4% |
(10.7)ppts |
Notes:
(1) Change in average headcount when compared to respective previous financial year ends.
(2) Adjusted staff costs and adjusted admin costs are measures calculated as staff costs or admin costs less share-based payment charges amounting to £5.0m (H1 FY25: £3.4m) and exceptional items amounting to £2.2m (H1 FY25: £nil). Exceptional items relate to staff restructuring costs.
As we continue to focus on delivering sustainable profitability through the economic cycle, we have reduced fixed costs while maintaining investment in our client service capabilities. As a result, our strong revenue performance is now supported by a leaner and better-aligned cost base.
Average headcount decreased by 9.4% since the end of H1 FY25 as we continued to actively manage headcount to ensure that the business operates efficiently whilst maintaining excellent client service. We also accelerated succession, bringing through the next generation of leaders in a number of areas of the business.
Fixed staff costs, including targeted salary increases to ensure that we remain competitive and retain key talent, have reduced by over £4.0m per annum, due to reduced headcount. Adjusted staff costs were higher than the prior year period, due to accrued variable remuneration associated with the increase in the Group's profitability.
Non-staff costs were lower than the corresponding H1 FY25 figure as a result of a review of significant technology contracts and continued discipline around other key areas of discretionary spend. Importantly, these cost savings have been achieved without compromising our strategic growth initiatives or client service capabilities.
Responsible business
As in previous years, we have remained committed to being a responsible business. A key part of this has been our engagement with local communities, including employee volunteer programmes and, this year, the launch of a new partnership with Uptree, a social mobility charity that supports under-represented groups in bridging the gap between education and employment. We have also continued to work toward our ESG targets, focusing on carbon emissions and diversity, with ongoing employee education programmes and initiatives led by our ESG forums.
Current trading and outlook
The Group has made a strong start to the second half, successfully completing several sizeable investment banking transactions, and performance from our Execution Services business, although down from the highs of the first half, has been robust. Consequently, we are confident in meeting market expectations for the full financial year.
Forward-looking statements
This announcement contains forward-looking statements. Forward-looking statements sometimes use words such as 'may', 'will', 'could', 'seek', 'continue', 'aim', 'anticipate', 'target', 'project', 'expect', 'estimate', 'intend', 'plan', 'goal', 'believe', 'achieve' or other words of similar meaning. Past performance is no guide to future performance and any forward-looking statements and forecasts are based on current expectations and assumptions but relate to events and depend upon circumstances in the future and you should not place reliance on them. These statements and forecasts are subject to various risks and uncertainties and there are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by forward-looking statements and forecasts.
The forward-looking statements contained in this document speak only as of the date of this announcement and (except as required by applicable regulations or by law) Peel Hunt does not undertake to publicly update or review any forward-looking statements, whether as a result of new information, future events or otherwise.
Nothing in this announcement constitutes or should be construed as constituting a profit forecast.
No offer of securities
The information, statements and opinions contained in this announcement do not constitute or form part of, and should not be construed as, any public offer under any applicable legislation, or an offer, or solicitation of an offer, to buy or sell any securities or financial instruments in any jurisdiction, or any advice or recommendation with respect to any securities or financial instruments.
There are a number of key judgement areas, which are based on models and which are subject to ongoing modification and alteration. The reported numbers reflect our best estimates and judgements at the given point in time.
CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
Consolidated Statement of Comprehensive Income
Unaudited for the six months ended 30 September 2025
|
|
|
|
Six months ended |
Six months ended |
|
|
|
|
30 Sep 2025 |
30 Sep 2024 |
|
|
Unaudited |
Unaudited |
||
|
Continuing activities |
|
Note |
£'000 |
£'000 |
|
Revenue |
|
2 |
74,368 |
53,787 |
|
|
|
|
|
|
|
Administrative expenses |
|
3 |
(62,161) |
(52,450) |
|
Profit from operations |
|
3 |
12,207 |
1,337 |
|
|
|
|
|
|
|
Finance income |
|
5 |
600 |
927 |
|
Finance expense |
|
5 |
(741) |
(1,129) |
|
Other income |
|
|
97 |
98 |
|
Operating profit for the period |
|
|
12,163 |
1,233 |
|
|
|
|
|
|
|
Share of loss from associate |
|
|
(668) |
- |
|
Profit before tax for the period |
|
|
11,495 |
1,233 |
|
|
|
|
|
|
|
Tax |
|
|
(3,177) |
(574) |
|
Profit for the period |
|
|
8,318 |
659 |
|
|
|
|
|
|
|
Other comprehensive income for the period |
|
|
- |
- |
|
Total comprehensive income for the period |
|
|
8,318 |
659 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Attributable to: |
|
|
|
|
|
Owners of the Company |
|
|
8,318 |
889 |
|
Non-controlling interests |
|
7 |
- |
(230) |
|
Total comprehensive income for the period |
|
|
8,318 |
659 |
|
Earnings per share - attributable to owners of the Company |
|
|
|
|
|
Basic |
|
6 |
7.2p |
0.8p |
|
Diluted |
|
6 |
6.5p |
0.7p |
Consolidated Balance Sheet
Unaudited as at 30 September 2025
|
|
|
|
As at 30 Sep 2025 |
As at 31 Mar 2025 |
|
|
|
|
Unaudited |
Audited |
|
|
|
Note |
£'000 |
£'000 |
|
ASSETS |
|
|
|
|
|
|
|
|
|
|
|
Non-current assets |
|
|
|
|
|
Property, plant and equipment |
|
|
5,343 |
5,715 |
|
Intangible assets |
|
|
455 |
1,658 |
|
Right-of-use assets |
|
|
11,028 |
12,069 |
|
Investment in associates |
|
|
2,058 |
- |
|
Deferred tax asset |
|
|
1,689 |
472 |
|
Total non-current assets |
|
|
20,573 |
19,914 |
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
Securities held for trading |
|
|
84,664 |
68,539 |
|
Market and client debtors |
|
|
601,819 |
496,029 |
|
Trade and other debtors |
|
|
21,262 |
20,042 |
|
Cash and cash equivalents |
|
|
13,630 |
20,395 |
|
Total current assets |
|
|
721,375 |
605,005 |
|
|
|
|
|
|
|
LIABILITIES |
|
|
|
|
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
Securities held for trading |
|
|
(56,336) |
(53,770) |
|
Market and client creditors |
|
|
(542,071) |
(447,146) |
|
Trade and other creditors |
|
|
(20,508) |
(8,859) |
|
Lease liabilities |
|
|
(2,983) |
(2,983) |
|
Long-term loans |
|
|
(6,000) |
(6,000) |
|
Provisions |
|
|
(677) |
(611) |
|
Total current liabilities |
|
|
(628,575) |
(519,369) |
|
|
|
|
|
|
|
Net current assets |
|
|
92,800 |
85,636 |
|
|
|
|
|
|
|
Non-current liabilities |
|
|
|
|
|
Long-term loans |
|
|
- |
(3,000) |
|
Lease liabilities |
|
|
(12,638) |
(13,833) |
|
Total non-current liabilities |
|
|
(12,638) |
(16,833) |
|
|
|
|
|
|
|
Net assets |
|
|
100,735 |
88,717 |
|
EQUITY |
|
|
|
|
|
Ordinary share capital |
|
|
40,099 |
40,099 |
|
Other reserves |
|
|
60,636 |
47,895 |
|
Total shareholders' equity |
|
|
100,735 |
87,994 |
|
Non-controlling interests |
|
|
- |
723 |
|
Total equity |
|
|
100,735 |
88,717 |
Consolidated Statement of Changes in Equity
Unaudited for the six months ended 30 September 2025
|
|
Ordinary Share Capital |
Other reserves |
Total shareholders' equity |
Non-controlling interests |
Total equity |
|
|
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
|
Balance as at 1 April 2024 |
40,099 |
50,076 |
90,175 |
1,575 |
91,750 |
|
Profit/(loss) for the period |
- |
889 |
889 |
(230) |
659 |
|
Other comprehensive income |
- |
- |
- |
- |
- |
|
Total comprehensive income/(expense) |
- |
889 |
889 |
(230) |
659 |
|
Transactions with owners |
|
|
|
|
|
|
Share based payments |
- |
2,837 |
2,837 |
- |
2,837 |
|
Purchase of Company shares |
- |
(476) |
(476) |
- |
(476) |
|
Balance as at 30 September 2024 |
40,099 |
53,326 |
93,425 |
1,345 |
94,770 |
|
Loss for the period |
- |
(3,617) |
(3,617) |
(622) |
(4,239) |
|
Other comprehensive income |
- |
- |
- |
- |
- |
|
Total comprehensive expense |
- |
(3,617) |
(3,617) |
(622) |
(4,239) |
|
Transactions with owners |
|
|
|
|
|
|
Share based payments |
- |
(1,316) |
(1,316) |
- |
(1,316) |
|
Purchase of Company shares |
- |
(498) |
(498) |
- |
(498) |
|
Balance as at 31 March 2025 |
40,099 |
47,895 |
87,994 |
723 |
88,717 |
|
Profit for the period |
- |
8,318 |
8,318 |
- |
8,318 |
|
Other comprehensive income |
- |
- |
- |
- |
- |
|
Total comprehensive income |
- |
8,318 |
8,318 |
- |
8,318 |
|
Transactions with owners |
|
|
|
|
|
|
Share based payments |
- |
4,330 |
4,330 |
- |
4,330 |
|
Non-controlling interests |
- |
- |
- |
(723) |
(723) |
|
Net movement in Company shares |
- |
93 |
93 |
- |
93 |
|
Balance as at 30 September 2025 |
40,099 |
60,636 |
100,735 |
- |
100,735 |
Consolidated Statement of Cash Flows
Unaudited for the six months ended 30 September 2025
|
|
|
|
Six months ended 30 Sep 2025 |
Six months ended 30 Sep 2024 |
|
|
|
|
Unaudited |
Unaudited |
|
|
|
Note |
£'000 |
£'000 |
|
Net cash generated from operations |
|
9 |
435 |
1,461 |
|
|
|
|
|
|
|
Cash flows from investing activities |
|
|
|
|
|
Purchase of tangible assets |
|
|
(398) |
(179) |
|
Purchase of intangible assets |
|
|
(35) |
(165) |
|
Derecognition of Retail Book cash on loss of control |
|
|
(1,774) |
- |
|
Net cash used in investing activities |
|
|
(2,207) |
(344) |
|
|
|
|
|
|
|
Cash flows from financing activities |
|
|
|
|
|
Interest paid |
|
|
(468) |
(775) |
|
Short term borrowings |
|
|
- |
(15,000) |
|
Lease liability payments |
|
|
(1,618) |
(1,754) |
|
Net cash movement in Company shares |
|
|
93 |
(476) |
|
Repayment of long-term loan |
|
|
(3,000) |
(3,000) |
|
Net cash used in financing activities |
|
|
(4,993) |
(21,005) |
|
|
|
|
|
|
|
Net decrease in cash and cash equivalents |
|
|
(6,765) |
(19,888) |
|
Cash and cash equivalents at start of period |
|
|
20,395 |
37,929 |
|
Cash and cash equivalents at end of period |
|
|
13,630 |
18,041 |
NOTES TO THE FINANCIAL STATEMENTS
1. Basis of preparation
Peel Hunt Limited (the 'Company') is a non-cellular company limited by shares having its shares admitted to trading on AIM, a market operated by London Stock Exchange plc, on 29 September 2021. The Company is registered in Guernsey. Its registered office is Mont Crevelt House, Bulwer Avenue, St Sampson, Guernsey GY2 4LH. The consolidated interim financial information of the Company comprise the Company and its subsidiaries, together referred to as the 'Group'.
The financial information contained within these condensed consolidated interim financial statements is unaudited and has been prepared in accordance with International Accounting Standard 34 Interim Financial Reporting ('IAS 34'). The Financial Statements should be read in conjunction with the annual financial statements for the year ended 31 March 2025, which have been prepared in accordance with UK-adopted international accounting standards (International Financial Reporting Standards ('IFRS') and International Financial Reporting Interpretations Committee ('IFRIC')) and with the requirements of the Companies (Guernsey) Law, 2008.
The preparation of the condensed consolidated interim financial statements in conformity with IAS 34 requires the use of certain critical accounting judgements and significant estimates. It also requires the Board of Directors to exercise its judgement in the application of the Group's accounting policies. The accounting policies applied are consistent with those of the annual financial statements for the year ended 31 March 2025.
The financial information is presented in pounds sterling and all values are rounded to the nearest thousand (£'000), except where indicated otherwise.
The financial information has been prepared on the historical cost basis, except for derivatives, financial assets and liabilities measured at Fair value through profit and loss ('FVTPL'). Historical cost is generally based on the fair value of the consideration given in exchange for the assets.
These condensed consolidated interim financial statements have been prepared on a going concern basis as the Directors have satisfied themselves that, at the time of approving these condensed consolidated interim financial statements, the Company and the Group have adequate resources to continue in operational existence for at least the next twelve months.
During the period, there were no new standards or amendments to IFRS that became effective and were adopted by the Company and the Group with a material impact.
2. Revenue
|
|
|
|
Six months ended 30 Sep 2025 |
Six months ended 30 Sep 2024 |
|
|
|
Unaudited |
Unaudited |
|
|
|
|
£'000 |
£'000 |
|
|
Research payments & Execution commission |
|
|
13,866 |
13,616 |
|
Execution services revenue |
|
|
27,581 |
17,592 |
|
Investment Banking revenue |
|
|
32,921 |
22,579 |
|
Total revenue for the period |
|
|
74,368 |
53,787 |
3. Profit from operations
The following items have been included in arriving at profit from operations:
|
|
|
|
Six months ended 30 Sep 2025 |
Six months ended 30 Sep 2024 |
|
|
Unaudited |
Unaudited |
||
|
|
£'000 |
£'000 |
||
|
Depreciation and amortisation |
|
957 |
923 |
|
|
Lease depreciation |
|
1,189 |
1,197 |
|
|
Staff costs (see note 4) |
|
43,058 |
32,865 |
|
|
Other non-staff costs |
|
|
16,957 |
17,465 |
|
Total administrative costs |
|
|
62,161 |
52,450 |
Other non-staff costs comprise expenses incurred in the normal course of business, including technology costs, professional and regulatory fees, auditors' fees, brokerage, clearing and exchange fees.
4. Staff costs
|
|
|
|
Six months ended 30 Sep 2025 |
Six months ended 30 Sep 2024 |
|
|
|
Unaudited |
Unaudited |
|
|
|
|
£'000 |
£'000 |
|
|
Wages and salaries |
|
|
31,278 |
24,488 |
|
Share based payment charges |
|
|
4,982 |
3,440 |
|
Social security costs |
|
|
5,406 |
3,492 |
|
Pensions costs |
|
|
1,192 |
1,385 |
|
Other costs |
|
|
200 |
60 |
|
Total staff costs charged as an expense for the period |
|
|
43,058 |
32,865 |
Wages and salaries include variable compensation accruals.
The average number of employees of the Group during the period has decreased to 269 (H1 FY25: 297). The number of employees of the Group at the end of the period has decreased to 270 (H1 FY25: 295).
5. Net finance expense
|
|
|
|
Six months ended 30 Sep 2025 |
Six months ended 30 Sep 2024 |
|
|
Unaudited |
Unaudited |
||
|
|
£'000 |
£'000 |
||
|
Finance income: |
|
|
|
|
|
Bank interest received |
|
600 |
927 |
|
|
|
|
|
|
|
|
Finance expense: |
|
|
|
|
|
Bank interest paid |
|
(109) |
(124) |
|
|
Interest on lease liabilities |
|
(273) |
(354) |
|
|
Interest accrued on loans |
|
|
(359) |
(651) |
|
Finance expense for the period |
|
(741) |
(1,129) |
|
|
|
|
|
|
|
|
Net Finance expense for the period |
|
(141) |
(202) |
|
6. Earnings per share
|
|
|
|
Six months ended 30 Sep 2025 |
Six months ended 30 Sep 2024 |
|
|
Number of shares |
Number of shares |
||
|
|
Unaudited |
Unaudited |
||
|
Weighted number of ordinary shares in issue during the period |
|
|
115,620,288 |
116,891,735 |
|
Dilutive effect of share option grants |
|
|
12,336,580 |
11,466,209 |
|
Diluted weighted average number of ordinary shares in issue during the period |
|
127,956,868 |
128,357,944 |
|
Basic earnings per share is calculated on total comprehensive income for the six-month period, attributable to owners of the Company, of £8.3m (H1 FY25: £0.9m) and 115,620,288 (H1 FY25: 116,891,735) ordinary shares, being the weighted average number of shares in issue during the period. Diluted earnings per share is calculated after adjusting for the number of options expected to be exercised from the share option grants.
The calculations exclude Company shares held by the Employee Benefit Trust on behalf of the Group.
The Company has 12,336,580 (H1 FY25: 11,466,209) of dilutive equity instruments outstanding as at 30 September 2025.
7. Non-controlling interest
The amount of non-controlling interest is measured at the non-controlling interest's proportionate share of the subsidiary's identifiable net assets. Non-controlling interest has been derecognised following loss of control in Retail Book during the period resulting from a shareholding dilution from 51.46% as at 31 March 2025 to 40.95% as at 30 September 2025.
8. Balance sheet items
(a) Property, plant and equipment
Property, plant and equipment is stated at cost less accumulated depreciation and impairment losses. Depreciation is charged to the Income Statement on a straight-line basis over the estimated useful economic lives of each item.
(b) Intangible assets
Intangible assets represent internal software intellectual property, computer software and sports debentures. Amortisation is charged to the Income Statement on a straight-line basis over the estimated useful economic lives of each item. Internal software intellectual property is amortised over 3 or 5 years, computer software is amortised over five years and sports debentures are amortised over the life of the ticket rights.
Internal software intellectual property represents internally-generated intangible assets and it comprises of capitalised development costs for certain technology developments for key projects in the Group. The costs incurred in the research phase of these internal projects are expensed. Intangible assets are recognised from the development phase if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its costs can be reliably measured. Amortisation begins when the asset is available for use.
(c) Right-of-use asset and lease liabilities
The right-of-use asset and lease liabilities (current and non-current) represent the two property leases that the Group currently uses for its offices in London and New York and car rental leases.
(d) Investment in associate
Retail Book is now recognised as an associate, with its assets, liabilities, and non-controlling interests derecognised from the Group's consolidated financial statements during the period. The carrying value of the investment was reduced from £3.2m gross investment as at 31 March 2025 to £2.1m. This reduction reflects the Group's share of Retail Book's losses and the loss recognised on initial recognition of investment in associate. See note 7 for further information.
(e) Market and client debtors and creditors
The market and client debtor and creditor balances represent unsettled sold securities transactions and unsettled purchased securities transactions, which are recognised on a trade date basis. The majority of open bargains were settled in the ordinary course of business (trade date plus two days). Market and client debtor and creditor balances in these financial statements include agreed counterparty netting of £17.4m (FY25: £10.0m).
(f) Financial instruments
Financial assets and financial liabilities are recognised in the Statement of Financial Position when the Group becomes a party to the contractual provisions of the financial instrument. The fair valuation hierarchy applied is consistent with that outlined in the FY25 audited financial statements. The value of 'Level 1' financial assets held by the Group at the end of H1 FY26 was £77.7m (FY25: £66.8m), 'Level 2' £5.8m (FY25: £0.7m) and 'Level 3' £1.1m (FY25: £1.0m). The value of 'Level 1' financial liabilities held by the Group at the end of H1 FY26 was £56.0m (FY25: £53.7m), 'Level 2' £0.0m (FY25: £0.0) and 'Level 3' £0.4m (FY25: £0.0m).
(g) Stock borrowing collateral
The Group enters into stock borrowing agreements with a number of institutions on a collateralised basis. Under such agreements securities are borrowed with a commitment to return them at a future date. The securities borrowed are not recognised on the Statement of Financial Position. The cash pledged is recorded on the Statement of Financial Position as cash collateral within trade and other debtors, the value of which is not significantly different from the value of the securities borrowed. The total value of cash collateral held on the Statement of Financial Position is £9.8m (FY25: £2.4m).
(h) Borrowings
The Group has a committed Revolving Credit Facility of up to £20.0m and an overdraft facility of up to £10.0m in order to further support its general corporate and working capital requirements.
As at 30 September 2025 the funding facilities were undrawn (FY25: £nil)
(i) Long-term loans
During the period we paid £3.0m of the principal repayments of the Senior Facilities Agreement. As at 30 September 2025 £6.0m (FY25: £9.0m) was outstanding.
(j) Post balance sheet events
There are no post balance sheet events.
9. Reconciliation of profit before tax to cash from operating activities
|
|
|
|
Six months ended 30 Sep 2025 |
Six months ended 30 Sep 2024 |
|
|
Unaudited |
Unaudited |
||
|
|
£'000 |
£'000 |
||
|
Profit before tax for the period |
|
|
11,495 |
1,233 |
|
|
|
|
|
|
|
Adjustments for: |
|
|
|
|
|
Depreciation and amortisation |
|
|
2,146 |
2,120 |
|
Movement in expected credit loss on financial assets held at amortised cost |
|
|
(207) |
289 |
|
Increase in provisions |
|
|
66 |
66 |
|
Share based payments - IFRS 2 charge |
|
|
4,330 |
2,837 |
|
Revaluation of Right-of-use asset and Lease liabilities |
|
|
(3) |
70 |
|
Net finance costs |
|
|
141 |
202 |
|
|
|
|
|
|
|
Changes in working capital: |
|
|
|
|
|
Increase in net securities held for trading |
|
|
(13,559) |
(146) |
|
Increase in net market and client debtors |
|
|
(10,872) |
(13,399) |
|
Increase/(decrease) in trade and other debtors |
|
|
(930) |
4,180 |
|
Increase in trade and other creditors |
|
|
6,867 |
3,071 |
|
Cash (used)/generated from operations |
|
|
(526) |
523 |
|
|
|
|
|
|
|
Interest received |
|
|
600 |
927 |
|
Corporation tax received |
|
|
361 |
11 |
|
Net cash generated from operations |
|
|
435 |
1,461 |
END
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 15 minutes ago City of London Investment Group
- 22 minutes ago BioPharma Credit
- 25 minutes ago BioPharma Credit
- 27 minutes ago Diageo
- 31 minutes ago Barr (A.G.)